We partner with inventors, research centers, and academic institutions leveraging our decades of experience and deep industry relationships to rapidly move novel therapeutic compounds into and through clinical development towards FDA approval.

Our Founders

Raised in excess of $2 billion
7 drugs approved by FDA
80 years combined experience financing biotech


Camelot’s pipeline includes therapeutics from inventors, research centers, academic institutions, and other companies around the globe. Our expertise is in oncology, neurologic disease, and orphan disease advancements.